Fig. 5From: Ginsenoside G-Rh2 synergizes with SMI-4a in anti-melanoma activity through autophagic cell deathCombination treatment with Rh2 and SMI-4a inhibited melanoma growth in a mouse xenograft model. a and b A375 xenografts were treated by 0.5% MC (vehicle control), 15 mg/kg SMI-4a, 30 mg/kg G-Rh2, or combination of SMI-4a and Rh2 every 2 days for weeks. The results are expressed as the mean ± SEM. *p < 0.05 and **p < 0.01Back to article page